Digene launch a campaign focusing on lifestyle-related hyperacidity

Company |  News | 0 Comment | 18 Apr, 2019

In order to meet the underlying need and reach a broader audience, Digene has launched a new campaign focusing on providing a scientific solution to lifestyle-related hyperacidity, with Tap...Read more

Roche launches Hemlibra in India

Company |  News | 0 Comment | 17 Apr, 2019

Roche announced that Emicizumab (Hemlibra) has been approved in India for Haemophilia A with factor VIII inhibitors. It is indicated as a prophylactic(preventive) treatment to prevent or re...Read more

TA Associates announces partnership with Indira IVF

Company |  News | 0 Comment | 15 Apr, 2019

TA Associates, global growth private equity firm has announced that it has completed a significant minority investment in Indira IVF, a leading India-based infertility treatment provider. F...Read more

Lupin launches Testosterone Gel

Company |  News | 0 Comment | 15 Apr, 2019

Lupin has announced the launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), having received an approval from the United States Food and Drug Administration (FDA). Lupin&rsq...Read more

Suven secures product patents in Israel, Japan, NZ, SL

Company |  News | 0 Comment | 16 Apr, 2019

Suven Life Sciences Ltd (Suven) has announced that the grant of one (1) product patent from Israel (257869), one (1) product patent from Japan (6466602), one (1) product patent from New Zea...Read more

Cipla launches Niveoli inhaler

Company |  News | 0 Comment | 12 Apr, 2019

Cipla has announced that it has launched Niveoli™, India’s first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targeting ...Read more

Lupin receives FDA approval for Testosterone Gel

Company |  News | 0 Comment | 11 Apr, 2019

Pharma major Lupin has announced that it has received approval for its Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation), from the United States Food and Drug Administration (FD...Read more

Lupin launches Fluoxetine Tablets USP

Company |  News | 0 Comment | 10 Apr, 2019

Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Flu...Read more

Alcon debuts as independent, publicly traded company

Company |  News | 0 Comment | 10 Apr, 2019

Alcon, the global leader in eye care dedicated to helping people see brilliantly has announced its debut as an independent, publicly traded company and the completion of its separation from...Read more

Novartis completes spin-off of the Alcon eye care devices business

Company |  News | 0 Comment | 10 Apr, 2019

Novartis has completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution to holders of Novartis shares and ADRs (American Depositary Receipts), wit...Read more

ViiV Healthcare’s Dovato gets USFDA nod to treat HIV-1

Company |  News | 0 Comment | 09 Apr, 2019

ViiV Healthcare, a subsidiary of GSK announced that the US Food and Drug Administration (FDA) approved Dovato, a complete, once-daily, single-tablet regimen of dolutegravir (DTG) 50 mg and ...Read more

Lupin Bioresearch Centre completes fifth successful USFDA inspection

Company |  News | 0 Comment | 08 Apr, 2019

Lupin has announced the successful completion of the United States Food and Drug Administration (U.S. FDA) inspection at its Lupin Bioresearch Centre (LBC) without any observations. As per...Read more

Syngene, BIRAC set up Centre for Advanced Protein Studies

Company |  News | 0 Comment | 05 Apr, 2019

Syngene International Ltd., a leading global contract research organization, has announced the opening of its Centre for Advanced Protein Studies (CAPS) by the Secretary, Department of Biot...Read more

Emcure launches world’s first generic Eribulin for treatment of metastatic breast cancer

Company |  News | 0 Comment | 04 Apr, 2019

Emcure Pharmaceuticals, a leading integrated global pharmaceutical company from India has announced the launch of the world’s first generic version of Eisai Pharmaceutical’s Hal...Read more

Lupin’s Pithampur Unit-3 (Indore) receives EIR from USFDA

Company |  News | 0 Comment | 02 Apr, 2019

Lupin has announced the receipt of the Establishment Inspection Report (EIR) for its Pithampur (Unit-3) facility. The inspection was conducted between October 8, 2018 to October 18, 2018. ...Read more

Zydus gets USFDA nod to treat pulmonary arterial hypertension

Company |  News | 0 Comment | 29 Mar, 2019

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies The company has received the final app...Read more

1mg Technologies gets ISO 27001 certification

Company |  News | 0 Comment | 28 Mar, 2019

There has been a huge information imbalance in the field of medicine and 1mg.com has been working towards providing reliable and authentic medicine related information to the consumers for ...Read more

Madras High Court upholds Kibow Biotech’s Indian patent for Renadyl

Company |  News | 0 Comment | 27 Mar, 2019

In a major victory for global patent standards and for efforts to offer Indian consumers top international healthcare options, Kibow Biotech Inc, USA was awarded a huge win on its Indian pa...Read more